Avantor Operating Income 2018-2025 | AVTR
Avantor annual/quarterly operating income history and growth rate from 2018 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Avantor operating income for the quarter ending June 30, 2025 was $0.129B, a 26.73% decline year-over-year.
- Avantor operating income for the twelve months ending June 30, 2025 was $1.039B, a 45.18% increase year-over-year.
- Avantor annual operating income for 2024 was $1.085B, a 55.77% increase from 2023.
- Avantor annual operating income for 2023 was $0.696B, a 38.38% decline from 2022.
- Avantor annual operating income for 2022 was $1.13B, a 16.25% increase from 2021.
| Avantor Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $1,085 |
| 2023 | $696 |
| 2022 | $1,130 |
| 2021 | $972 |
| 2020 | $707 |
| 2019 | $552 |
| 2018 | $414 |
| 2017 | $-210 |
| Avantor Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $129 |
| 2025-03-31 | $147 |
| 2024-12-31 | $638 |
| 2024-09-30 | $125 |
| 2024-06-30 | $176 |
| 2024-03-31 | $146 |
| 2023-12-31 | $183 |
| 2023-09-30 | $210 |
| 2023-06-30 | $72 |
| 2023-03-31 | $231 |
| 2022-12-31 | $252 |
| 2022-09-30 | $276 |
| 2022-06-30 | $296 |
| 2022-03-31 | $307 |
| 2021-12-31 | $214 |
| 2021-09-30 | $237 |
| 2021-06-30 | $255 |
| 2021-03-31 | $266 |
| 2020-12-31 | $205 |
| 2020-09-30 | $177 |
| 2020-06-30 | $167 |
| 2020-03-31 | $158 |
| 2019-12-31 | $152 |
| 2019-09-30 | $143 |
| 2019-06-30 | $119 |
| 2019-03-31 | $138 |
| 2018-12-31 | |
| 2018-09-30 | $132 |
| 2018-06-30 | $94 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.563B | $6.784B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.003B | 27.08 |
| CVS Health (CVS) | United States | $90.597B | 11.27 |
| Elevance Health (ELV) | United States | $69.715B | 9.38 |
| Cencora (COR) | United States | $58.790B | 19.58 |
| DiDi Global (DIDIY) | China | $29.369B | 31.20 |
| Labcorp Holdings (LH) | United States | $22.982B | 18.27 |
| Natera (NTRA) | United States | $22.227B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.490B | 0.00 |
| ICON (ICLR) | Ireland | $14.189B | 13.65 |
| Medpace Holdings (MEDP) | United States | $12.736B | 33.71 |
| CochLear (CHEOY) | Australia | $12.699B | 0.00 |
| Solventum (SOLV) | United States | $12.484B | 12.88 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.720B | 0.00 |
| Revvity (RVTY) | United States | $10.408B | 18.34 |
| Sonic Healthcare (SKHHY) | Australia | $7.992B | 0.00 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Charles River Laboratories (CRL) | United States | $7.606B | 14.43 |
| Bausch + Lomb (BLCO) | Canada | $5.133B | 34.52 |
| Sotera Health (SHC) | United States | $4.525B | 25.29 |
| BrightSpring Health Services (BTSG) | United States | $4.244B | 32.38 |
| KindlyMD (NAKA) | United States | $3.998B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.468B | 79.42 |
| Alignment Healthcare (ALHC) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.949B | 18.71 |
| Surgery Partners (SGRY) | United States | $2.931B | 36.87 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Premier (PINC) | United States | $2.106B | 19.53 |
| Progyny (PGNY) | United States | $1.989B | 42.06 |
| Ardent Health (ARDT) | United States | $1.826B | 7.05 |
| PACS (PACS) | United States | $1.788B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.560B | 26.41 |
| Pediatrix Medical (MD) | United States | $1.406B | 9.39 |
| Teladoc Health (TDOC) | United States | $1.270B | 0.00 |
| Omada Health (OMDA) | $1.236B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.159B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.809B | 4.74 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 9.31 |
| CareDx (CDNA) | United States | $0.666B | 12.27 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.09 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 6.98 |
| SBC Medicals (SBC) | United States | $0.438B | 9.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 26.63 |
| So-Young (SY) | China | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| LifeMD (LFMD) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.186B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |